Chubb (CB) Outlook Updated as Morgan Stanley Weighs Pricing and Valuation Trends

Chubb Limited (NYSE:CB) is included among the 10 Cash-Rich Stocks to Buy Now.

On December 16, Morgan Stanley analyst Bob Huang raised the firm’s price target on Chubb Limited (NYSE:CB) to $310 from $300 and kept an Equal Weight rating on the shares. He said the P&C insurance sector is dealing with familiar pressures, including softer pricing in property and heavier competition in personal auto. Still, attractive valuations and strong casualty pricing help offset those challenges, and Huang continues to view the industry as Attractive heading into 2026.

Chubb’s strength lies in its steady cash generation and global footprint. Over the past 12 months, the company has produced nearly $14.7 billion in free cash flow. That cash remains after expenses and supports share buybacks and dividend payments, while also funding future growth initiatives. This level of cash flow helps explain why Chubb Limited (NYSE:CB) has raised its dividend for 32 consecutive years.

Insurers also benefit from their investment portfolios as large allocations to high-quality bonds, including US Treasuries, generate reliable interest income alongside insurance premiums. When interest rates stay elevated, that income increases and adds a defensive layer to earnings. Through September 30, Chubb generated $4.8 billion in net investment income.

Chubb Limited (NYSE:CB) is a global insurance leader, helping individuals, families, and businesses assess risk, manage exposure, and protect against loss across markets worldwide.

While we acknowledge the potential of CB as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than CB and that has a 100x upside potential, check out our report about the cheapest AI stock.

READ NEXT: 13 Highest Paying Monthly Dividend Stocks to Buy and 15 Dividend Stocks With Low Payout Ratios and Strong Upside

Disclosure: None.